Exact Sciences Corp (EXAS) Posts Q2 Loss of 24c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Exact Sciences (EXAS) PT Bumped at Jefferies Post Q2
July 23, 2014 8:55 AM EDTJefferies analyst Brandon Couillard raised his price target but lowered estimates on Buy-rated Exact Sciences (NASDAQ: EXAS) following Q2 results.
Couillard comments, "EXAS' 2Q14 earnings call served as a forum for it to provide an update on the anticipated timing of upcoming FDA &... More
